Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?
Authors
Keywords
Gastric Cancer, Trastuzumab, Irinotecan, Advanced Gastric Cancer, Fluoropyrimidine
Journal
JOURNAL OF GASTROENTEROLOGY
Volume 51, Issue 5, Pages 506-507
Publisher
Springer Nature
Online
2016-02-18
DOI
10.1007/s00535-016-1184-2
References
View 2 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.